Journal Menu
► ▼ Journal Menu-
- Cancers Home
- Aims & Scope
- Editorial Board
- Reviewer Board
- Topical Advisory Panel
- Instructions for Authors
- Special Issues
- Topics
- Sections & Collections
- Article Processing Charge
- Indexing & Archiving
- Editor’s Choice Articles
- Most Cited & Viewed
- Journal Statistics
- Journal History
- Journal Awards
- Society Collaborations
- Conferences
- Editorial Office
Journal Browser
► ▼ Journal BrowserNeed Help?
Announcements
23 January 2026
Cancers | Highly Viewed Papers and Hot Topic Special Issues in Cancer Biomarkers
We are delighted to share a collection of highly viewed papers in cancer biomarkers that were published in Cancers (ISSN: 2072-6694) of 2025. In addition, some Special Issues on this topic are currently open for submission. The following is a list of articles and Special Issues that we believe may be of interest to you:
The list of relevant papers can be seen below:
“Guidance for the Clinical Use of the Breast Cancer Polygenic Risk Scores”
by Peeter Padrik, Neeme Tõnisson, Tone Hovda, Kristine Kleivi Sahlberg, Eivind Hovig, Luís Costa, Gonçalo Nogueira da Costa, Inna Feldman, Filipa Sampaio, Sander Pajusalu et al.
Cancers 2025, 17(7), 1056; https://doi.org/10.3390/cancers17071056
Available online: https://www.mdpi.com/2072-6694/17/7/1056
“Leveraging Vector-Based Gene Disruptions to Enhance CAR T-Cell Effectiveness”
by Beatriz C. Oliveira, Saaurav Bari and J. Joseph Melenhorst
Cancers 2025, 17(3), 383; https://doi.org/10.3390/cancers17030383
Available online: https://www.mdpi.com/2072-6694/17/3/383
“Detection of ESR1 Mutations in Tissue and Liquid Biopsy with Novel Next-Generation Sequencing and Digital Droplet PCR Assays: Insights from Multi-Center Real Life Data of Almost 6000 Patients”
by Srushti Borkar, Fenja Markus, Agnes Oetting, Stefanie Schmidt, Christine Vössing, David Horst, Markus Möbs, Elena I. Braicu, Frank Griesinger, Katja Horling et al.
Cancers 2025, 17(8), 1266; https://doi.org/10.3390/cancers17081266
Available online: https://www.mdpi.com/2072-6694/17/8/1266
“BAP1 Mutations and Pleural Mesothelioma: Genetic Insights, Clinical Implications, and Therapeutic Perspectives”
by Susana Cedres, Augusto Valdivia, Ilaria Priano, Pedro Rocha, Patricia Iranzo, Nuria Pardo, Alex Martinez-Marti and Enriqueta Felip
Cancers 2025, 17(9), 1581; https://doi.org/10.3390/cancers17091581
Available online: https://www.mdpi.com/2072-6694/17/9/1581
“Liquid Biopsy in HPV-Associated Head and Neck Cancer: A Comprehensive Review”
by Federica Maria Parisi, Mario Lentini, Carlos M. Chiesa-Estomba, Miguel Mayo-Yanez, Jerome R. Leichen, Matthew White, Giovanni Giurdanella, Salvatore Cocuzza, Maria Rita Bianco, Nicolas Fakhry et al.
Cancers 2025, 17(6), 977; https://doi.org/10.3390/cancers17060977
Available online: https://www.mdpi.com/2072-6694/17/6/977
“Circulating Tumor DNA in Prostate Cancer: A Dual Perspective on Early Detection and Advanced Disease Management”
by Stepan A. Kopytov, Guzel R. Sagitova, Dmitry Y. Guschin, Vera S. Egorova, Andrei V. Zvyagin and Alexey S. Rzhevskiy
Cancers 2025, 17(15), 2589; https://doi.org/10.3390/cancers17152589
Available online: https://www.mdpi.com/2072-6694/17/15/2589
Special Issues:
“Molecular and Genetic Biomarkers in Oral Squamous Cell Carcinoma”
Guest Editor: Prof. Dr. Kalu U.E. Ogbureke
Submission deadline: 30 June 2026

“Role of Cancer Biomarkers for Diagnosis, Prognosis and Targeted Therapy in Gastrointestinal Cancers”
Guest Editor: Dr. Ali Zaidi
Submission deadline: 30 June 2026

“Advances in Pancreatic Cancer: Exploring Biomarkers and Prognostic Predictors”
Guest Editor: Dr. Makoto Abue
Submission deadline: 30 June 2026

“Immune Biomarkers in Solid Tumors: From Peripheral Blood Parameters to Tissue-Based Indicators for Prognosis and Therapy Response”
Guest Editors: Dr. Ioannis P. Trontzas and Prof. Dr. Konstantinos Syrigos
Submission deadline: 28 April 2026

You can view and submit relevant papers to Cancers via the following link:
https://www.mdpi.com/journal/cancers.
Cancers Editorial Office